Skip to main content

Signaling Events Initiated by Kappa Opioid Receptor Activation: Quantification and Immunocolocalization Using Phospho-Selective KOR, p38 MAPK, and KIR 3.1 Antibodies

  • Protocol
  • First Online:
Book cover Signal Transduction Immunohistochemistry

Part of the book series: Methods in Molecular Biology ((MIMB,volume 717))

Abstract

Psychiatric disorders including anxiety, depression, and addiction are both precipitated and exacerbated by severe or chronic stress exposure. While acutely, stress responses are adaptive, repeated exposure to stress can dysregulate the brain in such a way as to predispose the organism to both physiological and mental illness. Understanding the neuronal chemicals, cell types, and circuits involved in both normal and pathological stress responses are essential in developing new therapeutics for psychiatric diseases. Varying degrees of stressor exposure cause the release of a constellation of chemicals, including neuropeptides such as dynorphin. Neuropeptidergic release can be very difficult to directly measure with adequate spatial and temporal resolution. Moreover, the downstream consequences following release and receptor binding are numerous and also difficult to measure with cellular resolution. Following repeated stressor exposure, dynorphin is released, binds to the kappa opioid receptor (KOR), and causes activation of KOR. Agonist-activated KOR becomes a substrate for G protein receptor kinase (GRK), which phosphorylates the Ser369 residue at the C-terminal tail of the receptor in the first step in the β-Arrestin-dependent desensitization cascade. Through the use of phospho-­selective antibodies developed and validated in the laboratory, we have the tools, to assess with fine cellular resolution, the strength of behavioral stimulus required for release, time course of the release, and regional location of release. We have gone on to show that following KOR activation, both ERK 1/2 and p38 MAP kinase phosphorylation are increased through use of commercially available phospho-selective antibodies. Finally, we have identified that one effector of KOR/p38MAP kinase is KIR 3.1 and have developed a phospho-selective antibody against the Y12 motif of this channel. Much like KOR and p38 MAP kinase, phosphorylation of this potassium channel increases following repeated stress. The following chapter discusses immunohistochemical and quantification methods used for phospho-selective antibodies used in various brain regions following behavioral manipulations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., and Chavkin, C. (2007) Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-­opioid-dependent dysphoria. J. Neurosci. 27, 11614–11623.

    Article  PubMed  CAS  Google Scholar 

  2. Bruchas, M. R., Xu, M., and Chavkin, C. (2008) Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2. Neuroreport 19, 1417–1422.

    Article  PubMed  CAS  Google Scholar 

  3. Thomas, G. M., and Huganir, R. L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173–83.

    Article  PubMed  CAS  Google Scholar 

  4. Bardo, M. T., and Bevins, R. A. (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153, 31–43.

    Article  CAS  Google Scholar 

  5. Bolshakov, V. Y., Carboni, L., Cobb, M. H., Siegelbaum, S. A., and Belardetti, F. (2000) Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses. Nat. Neurosci. 3, 1107–1112.

    Article  PubMed  CAS  Google Scholar 

  6. Bruchas, M. R., Macey, T. A., Lowe, J. D., and Chavkin, C. (2006) Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J. Biol. Chem. 281, 18081–18089.

    Article  PubMed  CAS  Google Scholar 

  7. Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., et al. (2009) Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc. Natl. Acad. Sci. U S A 106, 19168–19173.

    Article  PubMed  CAS  Google Scholar 

  8. McLaughlin, J. P., Xu, M., Mackie, K., and Chavkin, C. (2003) Phosphorylation of a ­carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. J. Biol. Chem. 278, 34631–34640.

    Article  PubMed  CAS  Google Scholar 

  9. Ippolito, D. L., Xu, M., Bruchas, M. R., Wickman, K., and Chavkin, C. (2005) Tyrosine phosphorylation of K(ir)3.1 in spinal cord is induced by acute inflammation, chronic neuropathic pain, and behavioral stress. J. Biol. Chem. 280, 41683–41693.

    Article  PubMed  CAS  Google Scholar 

  10. Clayton, C. C., Bruchas, M. R., Lee, M. L., and Chavkin, C. (2010) Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy. Mol. Pharmacol. 77, 339–347.

    Article  PubMed  CAS  Google Scholar 

  11. Ippolito, D. L., Temkin, P. A., Rogalski, S. L., and Chavkin, C. (2002) N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai. J. Biol. Chem. 277, 32692–32696.

    Article  PubMed  CAS  Google Scholar 

  12. Bausch, S. B., Patterson, T. A., Appleyard, S. M., and Chavkin, C. (1995) Immuno­cytochemical localization of delta opioid receptors in mouse brain. J. Chem. Neuroanat. 8, 175–189.

    Article  PubMed  CAS  Google Scholar 

  13. Pan, Z., Kao, T., Horvath, Z., Lemos, J., Sul, J. Y., Cranstoun, S. D., et al. (2006) A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J. Neurosci. 26, 2599–25613.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julia C. Lemos .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Lemos, J.C., Roth, C.A., Chavkin, C. (2011). Signaling Events Initiated by Kappa Opioid Receptor Activation: Quantification and Immunocolocalization Using Phospho-Selective KOR, p38 MAPK, and KIR 3.1 Antibodies. In: Kalyuzhny, A. (eds) Signal Transduction Immunohistochemistry. Methods in Molecular Biology, vol 717. Humana Press. https://doi.org/10.1007/978-1-61779-024-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-024-9_11

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-023-2

  • Online ISBN: 978-1-61779-024-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics